Precision Medicine

5 things to know about CRISPR and gene editing in the COVID era

Here's how precision medicine is evolving in the era of COVID-19. Image: REUTERS/Brendan McDermid

Trevor Martin

Chief Executive Officer and Co-Founder, Mammoth Biosciences

Tooba Durraze

Growth Strategies Lead, Strategic Intelligence, Global Leadership Fellow, World Economic Forum LLC

The Big Picture
Explore and monitor how Precision Medicine is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Precision Medicine

Have you read?


How is the World Economic Forum bringing data-driven healthcare to life?

Have you read?

    Image: World Economic Forum
    Don't miss any update on this topic

    Create a free account and access your personalized content collection with our latest publications and analyses.

    License and Republishing

    World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

    The views expressed in this article are those of the author alone and not the World Economic Forum.

    Related topics:
    Precision MedicineHealth and HealthcareCOVID-19Emerging TechnologiesHealthcare DeliveryGlobal Health
    Global Agenda

    The Agenda Weekly

    A weekly update of the most important issues driving the global agenda

    Subscribe today

    You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

    Research reveals the links between viruses and Alzheimer's disease

    Ruth Itzhaki

    November 24, 2022

    About Us
    Partners & Members
    Language Editions

    Privacy Policy & Terms of Service

    © 2023 World Economic Forum